People who quit smoking see their risk of cardiovascular disease immediately begin to drop, but it may take up to 16 years for their health to reach the level of someone who has never smoked, according to a new Vanderbilt study.

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

Pulmonary hypertension is a common complication of chronic diseases that occurs when there is increased blood pressure in the arteries carrying blood from the right side of the heart to the lungs.

Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.

Marshall H. Crenshaw, MD, assistant professor of Medicine in the Division of Cardiology, died Aug. 23. He was 62.

Medical teams at the Vanderbilt Transplant Center (VTC) are leading the way in utilization of hepatitis C-exposed donors for heart transplantation.

Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.